Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov 27;17(2):340-343.
doi: 10.1016/j.radcr.2021.10.040. eCollection 2022 Feb.

In-111 octreotide SPECT/CT in the early diagnosis of pulmonary sarcoidosis: A case report

Affiliations
Case Reports

In-111 octreotide SPECT/CT in the early diagnosis of pulmonary sarcoidosis: A case report

Roberto G Carbone et al. Radiol Case Rep. .

Abstract

Sarcoidosis is a granulomatous disease of unknown etiology. At present the best diagnostic imaging procedure to assess stage and activity of sarcoidosis is controversial. We report the case of a 50-year-old male admitted with a history of dyspnea and fatigue with past medical history negative for smoking, occupational and environmental risk factors. Physical examination, routine blood tests, and pulmonary function tests were normal except for hypercalciuria. A chest radiograph showed bilateral hilar lymphadenopathy. Single photon emission computed tomography and/or computed tomography (SPECT and/or CT) In-111 Octreotide (Octreoscan) scintigraphy confirmed morphologic involvement of bilateral hilar lymph nodes and a mediastinoscopy biopsy specimen provided diagnosis of pulmonary sarcoidosis (stage 0). This clinical case shows the effectiveness of In-111 Octreotide SPECT and/or CT in the early diagnosis of pulmonary sarcoidosis.

Keywords: In-111 Octreotide (Octreoscan); Positron-emission tomography (PET); Radiological imaging; Sarcoidosis; Single photon emission computed tomography and/or computed tomography (SPECT and/or CT).

PubMed Disclaimer

Figures

Fig 1 –
Fig. 1
SPECT and/or CT Octreoscan scintigraphy showed morphologic involvement of bilateral hilar lymph nodes which also had an increased uptake (14.3 U.I.), compared to the rest of the lung (7.8 U.I., normal value ≤10 U.I.). Chest radiograph showing initial hilar adenopathy confirmed by CT, In-111 Octreotide and SPECT and/or CT.
Fig 2 –
Fig. 2
Photomicrograph of the biopsy sample stained with hematoxylin and eosin showed a confluent sarcoid granulomata pattern in thoracic lymph nodes at 20x (A) and 200x (B) magnification. Features showed multinuclear giant cells, mononuclear phagocytes, and lymphocytes. No necrosis was present.

Similar articles

References

    1. Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011;183:573–581. - PMC - PubMed
    1. Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e26–e51. - PMC - PubMed
    1. Carbone R, Filiberti R, Grosso M, Paredi P, Peano L, Cantalupi D, et al. Octreoscan perspectives in sarcoidosis and idiopathic interstitial pneumonia. Eur Rev Med Pharmacol Sci. 2003;7:97–105. - PubMed
    1. Lebthai R, Crestani B, Belmatoug N, Daou D, Genin R, Dombret MC, et al. Somatostatin receptor scintigraphy and Gallium scintigraphy in patients with sarcoidosis. J Nucl Med. 2001;42:21–26. - PubMed
    1. Cameli P, Caffarelli C, Refini MR, Bergantini L, D’Alessandro M, Armati M, et al. Hypercalciuria in sarcoidosis: a specific biomarker with clinical utility. Front Med (Lausanne) 2020;7 doi: 10.3389/fmed.2020.568020. - DOI - PMC - PubMed

Publication types

LinkOut - more resources